Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine vs Fluoxetine in Postmenopausal Women with MDD
NCT01824433Phase 4Completed
- Sponsor
- Capital Medical University
- Start
- Mar 2013
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine in major depressive disorder (MDD), sponsored by Capital Medical University. Started Mar 2013; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01824433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01824433.